Martin Shkreli

Martin Shkreli
Contributor since: 2011
Company: MSMB Capital
Debt Burden Makes Horizon Pharma An Attractive Short
Nektar Phase III Trials At Risk
MannKind Is Simply Running Out Of Cash
Ampio Is A Compelling Short Sale Idea
Avanir - Closing Short Position